About Libra Merger
Libra Merger was founded in 2023 in Israel, where operations center on the pharmaceutical sector. Generic drugs are produced as cost-effective alternatives to branded medications. Manufacturing processes are managed to meet regulatory standards, with distribution facilitated through the domain libramerger.tcc.mode. The companys activities are confined to Israels location, supporting access to essential medicines in regional markets.
- Headquarter Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Sun Pharma
(Jan 03, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Libra Merger
Detailed funding history for Libra Merger
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Libra Merger
Libra Merger has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sun Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
|
Locked | Locked | Locked |
Investor details for Libra Merger
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Libra Merger
Investment portfolio details for Libra Merger
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Libra Merger
Detailed financials for Libra Merger
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Libra Merger Comparisons
Peer comparison for Libra Merger
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Libra Merger
Detailed competitors of Libra Merger
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Libra Merger
Complete news archive for Libra Merger
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Libra Merger
Libra Merger was founded in 2023.
Libra Merger is headquartered in Israel.
Libra Merger was founded in 2023 in Israel, where operations center on the pharmaceutical sector. Generic drugs are produced as cost-effective alternatives to branded medications. Manufacturing processes are managed to meet regulatory standards, with distribution facilitated through the domain libramerger.tcc.mode. The companys activities are confined to Israels location, supporting access to essential medicines in regional markets.
Libra Merger has 1 investor. Key investors include Sun Pharma.